| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |